Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients

Figure 5

Validation of AP000695.2 expression and prognostic value in STAD patients. (a) The mRNA expression level of AP000695.2 in 78 paired STAD tumor tissues and adjacent normal tissues using real-time quantitative PCR (qRT-PCR). GAPDH was used as an endogenous control. The correlations between AP000695.2 expression and tumor size (b), T stage (c), lymph node metastasis (d), metastasis (e), and TNM stage (f) were analyzed.

(a)

(b)

(c)

(d)

(e)

(f)